Lars Ekman

Lars Ekman has an estimated net worth of $14 Million. This is based on reported shares across multiple companies, which include SOPHIRIS BIO INC., AMARIN CORP PLC\UK, ARYx Therapeutics, Inc., PROTHENA CORP PUBLIC LTD CO, Ultragenyx Pharmaceutical Inc., Spark Therapeutics, Inc., INTERMUNE INC, and Ocera Therapeutics, Inc..

2019 was Lars Ekman's most active year for acquiring shares with 19 total transactions. Lars Ekman's most active month to acquire stocks was the month of April. 2019 was Lars Ekman's most active year for disposing of shares, totalling 28 transactions. Lars Ekman's most active month to dispose stocks was the month of August. 2019 saw Lars Ekman paying a total of $1,348,451.43 for 437,263 shares, this is the most they've acquired in one year. In 2019 Lars Ekman cashed out on 839,321 shares for a total of $7,882,606.06, their largest year based on trade value.